AutoImmune Studies

Rheumatoid Arthritis
Multiple Sclerosis
Rheumatic Fever

 

Rheumatoid Arthritis

There was an extensive study done on 148 patients with an average of 9.1 yrs of Rheumatoid Arthritis.  It was reported that 27 patients were is stage I, 50 in stage II, 55 in stage III, and 16 in stage IV.  These were divided into 5 groups.  Four that received varying amounts of LBI at differing frequencies. The last being a placebo group.  Results were clear that those in earlier stages of RA were significantly helped and the more severe the patients condition the more difficult.

In a study on rheumatoid arthritis the clinical trials showed that there is a placebo effect on having treatments.  This is well documented but it was nowhere near as good as the response of two groups that were given more consistent and frequent treatments.

In severe cases of rheumatoid arthritis UBI can exacerbate the condition, presumably where irreparable joint damage had occurred but in moderate to mild cases UBI was shown to be very beneficial.

(Zvereva, 29-32)

 

Multiple Sclerosis

There is not much information at this point on M.S.

One doctors observation with five patients was that two improved dramatically.  One patient recovered from terminal stage M.S. after four sessions of UBI and lived a relatively normal life for some years.

 

Rheumatic Fever 

An older study documented 108 Children with rheumatic fever.  Out of these patients 22 were hospitalized with acute rheumatic carditis.  Another two were in severe condition. All the patients received UBI treatment.  One patient in severe condition died.  The rest were able to leave the hospital without any sign of rheumatic activity.  They received prophylactic treatment over the next several years. There were only two reoccurrences and those were successfully treated.  In contrast to other common drug therapies there was not a single report of toxicity.

(Wasson,15-33)

Translate »